He argued that successive administrations had sought policies to promote cassava inclusion in edible flour, recognising its cost-saving potential and economic benefits. He added that the ongoing ...

The Nigerian Senate has advanced efforts to mandate the inclusion of cassava in flour production and its derivatives. This development occurred yesterday in Abuja following the second reading of a ...

A bill seeking to mandate the inclusion of high-quality cassava flour in edible wheat flour production has passed its second reading in the Senate. Sponsored by Senator Saliu Mustapha (APC ...

The Senate has advanced moves to mandate the inclusion of 20% high-quality cassava flour in wheat used by all producers of edible flour in Nigeria or imported into the country, as a bill to this ...

The Senate Tuesday, sought for inclusion of cassava in flour production and its derivatives. Senate’s decision followed the passage of a bill sponsored to that effect by Sen. Saliu Mustapha(APC ...

Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trial, causing the stock to plummet ~90% and trade near book value. The company's decision to discontinue other simufilam trials ...

After hours: November 29 at 4:59 PM EST Loading Chart for SAVA ...

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Deep-pocketed investors have adopted a bullish approach towards Cassava Sciences (NASDAQ:SAVA), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...